AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06390735 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mommy ReachOut Intervention
Description: The momy reachOut intervention is a web-based psycho-education with 4 sessions, released over a two week period.
Study NCT05914610 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Envolimab
Description: Envolizumab 300mg, D1, ih, Q3W 4-6cycles
Study NCT05914610 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fruquintinib
Description: Fruquinitinib 3mg/d, QD, PO, D1-D14, Q3W 4-6cycles
Study NCT05914610 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxaliplatin
Description: Oxaliplatin 130 mg/m2, ivgtt 0-2h, D1, Q3W 4-6cycles
Study NCT05914610 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oxaliplatin
Description: Oxaliplatin 130 mg/m2, ivgtt 0-2h, D1, Q3W 4-6cycles
Study NCT05914610 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tegafur
Description: Tegafur was calculated according to body surface area , P.O., bid, d1-d14#And the dosage according body surface area:\<1.25m2, 40mg every time;1.25-1.5m2,50mg every time; >1.5m2, 60mg every time Q3W 4-6cycles
Study NCT05914610 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tegafur
Description: Tegafur was calculated according to body surface area , P.O., bid, d1-d14#And the dosage according body surface area:\<1.25m2, 40mg every time;1.25-1.5m2,50mg every time; >1.5m2, 60mg every time Q3W 4-6cycles
Study NCT06535074 — intervention group
Intervention type: OTHER
Intervention: Detecting changes in lung volume with hypoxemia episodes
Description: Electrical impedance tomography (EIT) will be used to assess changes in lung aeration prior and during hypoxemia episodes to classify them into four different subtypes.~FE subtype: Defined as HEs preceded by reduction in EELI below the baseline.~Apnea subtype: Defined as HEs not meeting the criteria for FE subtype and preceded by cessation of breathing.~Mixed subtype: Defined as HEs meeting the criteria for both FE and apnea subtypes.~Unclassified: Defined as HEs not categorized into any of the above parameters.
Study NCT06535412 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IMC-002 + SOC
Description: intravenous injection of 0.8mg/kg、1.2mg/kg and1.6mg/kg
Study NCT06535412 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo + SOC
Description: intravenous injection of Placebo
Study NCT06551454 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Smart Textile Solution Biofeedback Method
Description: The Smart Textile Solution Biofeedback Method for injury prevention in youth league football players integrates sensors within socks to monitor key biomechanical indicators such as center of pressure and plantar pressure of the foot in real-time. By providing immediate feedback and alerts on potential injury risks, the system helps players adjust their techniques during training sessions and prevent injuries during training and games.
Study NCT06551454 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Smart Textile Solution Biofeedback Method
Description: The Smart Textile Solution Biofeedback Method for injury prevention in youth league football players integrates sensors within socks to monitor key biomechanical indicators such as center of pressure and plantar pressure of the foot in real-time. By providing immediate feedback and alerts on potential injury risks, the system helps players adjust their techniques during training sessions and prevent injuries during training and games.
Study NCT05224206 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Theta burst stimulation
Description: Cool B65 active/placebo coil (left DLPFC) with X100 MagPro rTMS Device (Magventure A/S, Farum, Denmark)
Study NCT05224206 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Theta burst stimulation
Description: Cool B70 coil (left DLPFC), with X100 MagPro rTMS Device (Magventure A/S, Farum, Denmark)
Study NCT05496595 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DCBY02
Description: A monoclonal antibody that binds to CD93, DCBY02 will be administered as a single intravenous (IV) infusion on Day 1 in each 21-day cycle.
Study NCT05298085 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxytocin nasal spray
Description: Study treatment will be administered intranasally daily for 12 weeks. The daily dose of OT will be adapted according to age at the beginning of the study
Study NCT05298085 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Study treatment will be administered intranasally daily for 12 weeks.
Study NCT05418257 — intervention group
Intervention type: OTHER
Intervention: (exposure) telemedicine
Description: medical counseling or treatment only using phone
Study NCT05658289 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Coracoid Transfer
Description: For patients randomized to the active comparator group, the coracoid process and conjoined tendon will be cut and transferred to the anterior rim of the glenoid through an incision in the subscapularis muscle.
Study NCT05658289 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Distal Tibia Allograft with Bankart repair
Description: For the experimental group, a distal tibia allograft will be prepped, cut (20mm x 10mm x 15mm), and inserted into the anterior aspect of the shoulder through a far medial portal. The distal tibia allograft will be attached to the anterior glenoid using cannulated screws. A soft tissue repair, Bankart repair, is performed above the graft.
Study NCT06290258 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplantation
Description: Fecal microbiota transplantation has been applied to patients with autism spectrum disorder in recent years. Fecal microbiota of healthy donors can be transplanted to patients through colonoscopy. Before donation, donors were comprehensively screened to rule out gastrointestinal symptoms and infections. Patients will receive colon preparation before transplantation. After the intervention, patients will have to stay in bed and be monitored for 24 hours to assure safety.
Study NCT05291156 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cetuximab
Description: Cetuximab will be administered at 1st dose at 400 mg/m2 by i.v. infusion over 120 minutes.~The 2nd dose and subsequent doses will be performed at 250 mg/ m2 by i.v. infusion over 60 minutes, every week.
Study NCT05291156 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cetuximab
Description: Cetuximab will be administered at 1st dose at 400 mg/m2 by i.v. infusion over 120 minutes.~The 2nd dose and subsequent doses will be performed at 250 mg/ m2 by i.v. infusion over 60 minutes, every week.
Study NCT05879744 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CLN-978
Description: CD19xCD3 T cell engager
Study NCT05291156 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Avelumab
Description: Avelumab will be administered as a 1-hour IV infusion at flat dose of 800 mg every 2-week treatment cycle.
Study NCT05152407 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Topical application of MRB 0.3% serum and placebo serum (hemi face or skull)
Description: Serums will be topically applied twice a day (mornings and evenings).
Study NCT05166473 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telerehabilitation group (n=21)
Description: This group was conducted with a physiotherapist for video conference-based vestibular rehabilitation exercises, was called the telerehabilitation group (TR). In terms of ease of Use and applicability, the WhatsApp app was preferred. Patients were individually searched for two days a week, 25-30 minutes. The exercises were performed gradually from easy to difficult, initially in a sitting position in accordance with the levels of the patients.
Study NCT05166473 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control Group (n=21)
Description: After the home exercise program, which should be applied twice a day for six weeks, was shown in practice, the home exercise program was given, in which the exercises were visual and written, this group was called the control group. All participants were given a phone number to consult when there were any problems, and were phoned to decry whether they were continuing the exercises.
Study NCT06542861 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High-frequency simulation-based team training
Description: The intervention is a standardized high-frequency training program as described in intervention arm. It is supported by four preliminary initiatives:~1. 15 extra pediatric simulation facilitators were educated, bringing the total number up to 40.~2. A two-day pre-intervention workshop for all pediatric simulation facilitators.~3. A scenario bank containing standardized scenarios on common pediatric and neonatal emergencies was created and made accessible for simulation facilitators to support consistency in the intervention.~4. Purchase of equipment. Eight Leardal manikins. Four SimPads. Four monitors. During the intervention year, these will rotate between the pediatric departments.
Study NCT05212831 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Inogen One® G4
Description: Inogen One® G4 will be used for a minimum of 3h per day at Setting 3 during the intervention period.
Study NCT04778007 — intervention group
Intervention type: OTHER
Intervention: Turkish Version of Laryngopharyngeal Measure of Perceived Sensation Questionnaire
Description: The Turkish Version of Laryngopharyngeal Measure of Perceived Sensation Questionnaire consists of 8 questions related with globus pharyngeus symptoms.
Study NCT06336226 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Brachio basilic arterio venous fistula one stage versus two stage
Description: Comparative study between one stage brachio basilic arterio venous fistula versus two stage
Study NCT05610982 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Yoga Program
Description: The yoga program involves two weekly 60-minute group-based classes. Participants can attend in-person or online (via Zoom). In total, 24 classes will be offered across 12 weeks. The program structure has been developed and approved by certified yoga instructors (n=12) and adults diagnosed with gynecologic cancer (n=6). The classes will follow a flexible base class that the instructor can then adapt as they see fit to promote participants' comfort, safety, and engagement. The program will also include group discussions and journaling that participants may participate in, if they choose. Finally, participants will be encouraged to access an online database of pre-recorded short-duration yoga practices to support their at-home practice.
Study NCT05983029 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Intergluteal Cleft
Description: Marking of intersection between inferior aspect of the intergluteal cleft and the horizontal intercristal line
Study NCT05983029 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Neuraxial Midline
Description: Marking of intersection between the neuraxial midline, as established with the transverse spinous process view on ultrasound, and the horizontal intercristal line
Study NCT05983029 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Horizontal Distance between Vertical Markings
Description: The horizontal distance between these two vertical marks will be measured at the level of the intercristal line
Study NCT05920018 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Vivomixx®
Description: Daily application of four sachets, i.e. 1.800 bio bacteria/day for 48 weeks
Study NCT05920018 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Conjugated linoleic acid (CLA/Tonalin® FFA 80)
Description: Daily application of two capsules p.o., i.e. 2g/day for 48 weeks
Study NCT05920018 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Maltose placebo
Description: Daily application of four sachets for 48 weeks
Study NCT05920018 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Sunflower oil placebo
Description: Daily application of two capsules p.o for 48 weeks
Study NCT05050357 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Hormonal intrauterine device
Description: insertion of hormonal IUD during menstrual period
Study NCT05050357 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Progestins Norethindrone
Description: oral ethisteron twice daily for three months
Study NCT05410574 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family-based Behavioral Weight Loss Treatment
Description: The treatment includes: 1) the Traffic Light Eating Plan; 2) the Traffic Light Activity Program, 3) a variety of behavioral change strategies e.g., stimulus control, self-monitoring, planning, goal setting and 4) facilitation of support in the family and peer environments to optimize the durability and generalizability of health habits across multiple social and environmental contexts
Study NCT05110430 — intervention group
Intervention type: OTHER
Intervention: Deep learning based detection of metastatic bone disease on bone scintigraphy scans.
Description: The aim is to investigate whether deep learning algorithms can detect bone metastasis with high accuracy and specificity.
Study NCT05817084 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: medial opening wedge high tibial osteotomy
Description: medial opening wedge valgus high tibial osteotomy
Study NCT05817084 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: anterior cruciate ligament reconstruction
Description: anterior cruciate ligament reconstruction
Study NCT04911673 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: music
Description: Participants listened a song with headphones that lasts 29 minutes and 32 seconds for four days (three days before menstruation and the first day of menstruation).
Study NCT04911673 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Chocolate group
Description: Participants ate 40 mg of dark chocolate with 60% cocoa per a day for four days (three days before menstruation and the first day of menstruation) that was given by researchers to them.
Study NCT06102837 — intervention group
Intervention type: BIOLOGICAL
Intervention: tumor vaccine
Description: tumor vaccine produced by our team
Study NCT06102837 — intervention group
Intervention type: RADIATION
Intervention: Radiotherapy
Description: conventional treatment in clincial
Study NCT06102837 — intervention group
Intervention type: DRUG
Intervention: Chemotherapy
Description: conventional treatment in clinical
Study NCT06102837 — intervention group
Intervention type: PROCEDURE
Intervention: Surgery
Description: conventional treatment in clinical
Study NCT05843942 — intervention group
Intervention type: OTHER
Intervention: Questionnaire
Description: A food frequency questionnaire that was designed to assess folate, iron, and vitamin B12 intake will be administered. Furthermore a 24-hour recall food record will be administered and a complete blood count will be collected. Food frequency questionnaire data will be compared to recall food records and blood count data.
Study NCT06086223 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: ankle arthroscopy with ORIF
Description: we will go for fixation of the fracture with association of scope intervention pre and post fixation
Study NCT06086223 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: fracture ankle fixation without ankle arthroscopy
Description: we will go for fixation of the fracture alone with no scope intervention
Study NCT06530316 — intervention group
Intervention type: DRUG
Intervention: RET Inhibitor
Description: RET inhibitors for neoadjuvant treatment
Study NCT06530316 — intervention group
Intervention type: PROCEDURE
Intervention: Surgery
Description: Operable patients receive surgery after neoadjuvant therapy
Study NCT04408963 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VRC-HIVMAB0102-00-AB
Description: The VRC-HIVMAB0102-00-AB (CAP256V2LS) broadly neutralizing monoclonal antibody (bNAb) targets the V1V2 region of the HIV-1 envelope, is human in origin, and contains two amino acid modifications within the C-terminus of the heavy chain constant region designed to improve antibody half-life in vivo.
Study NCT06141135 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Preimplantation genetic testing for aneuploidy (PGTA)
Description: 24 chromosome screening for aneuploidy in the preimplantation embryo(blastocyst stage)
Study NCT05605457 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PRG barrier coat + nanohybrid composite
Description: It is a light cured surface-partially reacted glass (S-PRG) filler particles with a multifunctional glass core embedded in a resin matrix.
Study NCT05605457 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: resin modified glass ionomer
Description: RMGIC are glass-ionomer cements with small quantity of monomers and initiators so the acid-base reaction is supplemented by a second polymerization reaction
Study NCT05736952 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral Topotecan Combined With Anlotinib
Description: Topotecan hydrochloride capsules: 2 mg, once daily, oral with dinner for 5 days, discontinued for 16 days, that is, 21 days (3 weeks) as a course of treatment, a total of 6 courses of administration.；Anlotinib hydrochloride capsules: 10mg once a day, oral before breakfast, continuous administration for 14 days, discontinuation for 7 days, that is, 21 days (3 weeks) as a course of treatment.
Study NCT06170333 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 8% sulphur and A. vera soap
Description: Patients in experimental arms will receive the combination of 8% sulphur and A. vera soap for four weeks along with 2% ketoconazole shampoo for a week.
Study NCT06170333 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 8% sulphur and A. vera soap
Description: Patients in experimental arms will receive the combination of 8% sulphur and A. vera soap for four weeks along with 2% ketoconazole shampoo for a week.
Study NCT05239091 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dextrose solution
Description: A total of 3 doses of dextrose prolotherapy will be administered with an interval of 2 weeks.
Study NCT05239091 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lidocain
Description: A total of 3 doses of lidocaine will be administered with an interval of 2 weeks.
Study NCT05181761 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Gel Polish
Description: One hand of a subject with receive nail polish to compare bacterial growth between hands with gel nail polish to those without.
Study NCT04717999 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: NKG2D CAR-T
Description: The NKG2D CAR-T will be administrated via intracerebroventricular injection through an Ommaya catheter. Standard treatments such as temozolomide will be stopped during the infusion of NKG2D CAR-T.
Study NCT06165510 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Epicardial AF ablation using AtriCure EPi-Sense-AF Guided Coagulation System with Left Atrial Appendage Exclusion using the AtriCure LARIAT Suture Delivery Device.
Description: 2 stage procedure - minimally-invasive epicardial ablation with left atrial appendage exclusion using LARIAT procedure via a subxiphoid incision. This is then combined with endocardial radiofrequency catheter ablation in a separate staged procedure.
Study NCT06165510 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Standard Endocardial Catheter Ablation
Description: Standard percutaneous endocardial catheter ablation of atrial fibrillation
Study NCT05409443 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Nimbus Sacroiliac Joint Radiofrequency Ablation (N-SIJRFA)
Description: * Electrodes are positioned along the lateral sacral crest lateral to the inflection points of the S1, S2 and S3 lateral foraminal walls along first to third transverse sacral tubercles maintaining a craniocaudal line with an interelectrode distance of no more than 15mm.~* The appropriate locations are confirmed in both AP and lateral views and the tines are deployed. Following injection of lidocaine, lesions are performed at 85 degrees Celsius for 180 seconds at each site for bipolar sites and 80 degrees Celsius for 90 seconds for the monopolar site. Following ablation, the tines are retracted for all electrodes prior to removal.
Study NCT05409443 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Sacroiliac Joint Radiofrequency Ablation (C-SIJRFA)
Description: * To target the L4 medial branch and L5 dorsal ramus, an electrode will be placed in parallel between the junction of the L5 transverse process and superior articular process and the sacral ala and S1 superior articular process.~* A periforaminal electrode position will be used to target the lateral branches from S1 to S3. An 22-G cannula with a 5-mm exposed tip will be directed to a location approximately 3-5mm lateral to the PSFA of S1, S2, and S3. The analog clock positions for the probes at S1 and S2 levels will be 1:00, 3:00, and 5:30 on the right, and 6:30, 9:00, and 11:00 on the left. For the S3 level the positions at 1:30 and 4:30 on the right, and 7:30 and 10:30 on the left will be used (6,18).~* The appropriate locations are confirmed in both AP and lateral views. Following injection of lidocaine, monopolar RFA is performed for 90 seconds at 80 degrees Celsius at each location.
Study NCT06646666 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: All-trans retinoic acid
Description: 10mg，tid，po (After apheresis and continued until post-infusion)
Study NCT06646666 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: zanubrutinib
Description: 160mg，bid，po (prior to apheresis and continued until post-infusion)
Study NCT06646666 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: radiotherapy
Description: If the patient's specific lesions are suitable for radiotherapy
Study NCT06646666 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CAR-T
Description: CAR-T cell therapy